IPO Journey

PERSHING SQUARE INC.

IPO Date: April 30, 2026 · 5 filings tracked

Final Offer Terms

Ticker
PS
Exchange
New York Stock Exchange
Offer Price
$0.00
Shares Offered
8,103,392
Estimated Proceeds
$0.0
Underwriters

Led by Citigroup, UBS Investment Bank

Filing Timeline

1
S-1
March 10, 2026
  • Access to Bill Ackman’s high-conviction, activist investment strategy
  • Simplified U.S. retail access via the new PSUS closed-end fund
2
S-1/A
April 13, 2026
  • Permanent capital model allows for long-term investment strategies without liquidity-driven sell-offs.
  • Proven turnaround success with significant growth in assets since 2018.
3
S-1/A
April 20, 2026
  • Access to a high-conviction portfolio of 8-12 large-cap companies
  • Permanent capital structure allows for long-term holding without liquidity-driven sell-offs
4
S-1/A
April 23, 2026
  • Access to Bill Ackman’s proven investment strategy
  • Unique 'bundle' structure offering free Pershing Square Inc. shares with PSUS investment

Changes from previous filing

  • Shares offered: 33,120,000
424B4 Final Pricing
April 30, 2026
  • Access to institutional-grade investment management for retail investors
  • Permanent capital model allows for long-term, patient investment strategies

Changes from previous filing

  • Final offer price: $0.0 per share
  • Shares offered: 8,103,392
  • Estimated proceeds: $0M
  • Underwriters: Citigroup, UBS Investment Bank, BofA Securities, Jefferies, Wells Fargo Securities, RBC Capital Markets, BTG Pactual, Keefe, Bruyette & Woods, Inc., Academy Securities, Huntington Capital Markets, Loop Capital Markets, Oppenheimer & Co., Piper Sandler, Roberts & Ryan, Wedbush Securities, Aegis Capital Corp., AmeriVet Securities, C.L. King & Associates, CastleOak Securities, L.P., Clear Street, InspereX, Jones, R. Seelaus & Co., LLC, Samuel A. Ramirez & Company, Inc., Siebert Williams Shank, Tigress Financial Partners
Disclaimer: AI-generated analysis for informational purposes only. Not financial advice. Always conduct your own research.